Literature DB >> 3032091

Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.

D V Savani, J R Perfect, L M Cobo, D T Durack.   

Abstract

We studied the penetration of three azole compounds, ketoconazole, itraconazole, and fluconazole, into the ocular tissues and fluids of rabbits in the presence and absence of ocular inflammation. Drug concentrations were compared with those found in serum and cerebrospinal fluid. The rank order of penetration into eye tissue was fluconazole greater than ketoconazole greater than itraconazole. Fluconazole penetrated freely into both inflamed and uninflamed eyes. The presence of inflammation improved penetration of all three compounds into ocular fluids and tissues. Penetration of these azoles into the anterior chamber of uninflamed eyes and into the cerebrospinal fluid was similar. All three azole compounds reduced the number of yeasts found in the eye in hematogenous Candida albicans endophthalmitis in rabbits when therapy was initiated within 24 h of inoculation. However, only ketoconazole significantly reduced yeast counts in the eye when therapy was postponed for 7 days.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032091      PMCID: PMC174641          DOI: 10.1128/AAC.31.1.6

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Dissecting ocular tissue for intraocular drug studies.

Authors:  R Abel; G L Boyle
Journal:  Invest Ophthalmol       Date:  1976-03

2.  Therapy of postsurgical fungal endophthalmitis.

Authors:  D B Jones
Journal:  Ophthalmology       Date:  1978-04       Impact factor: 12.079

3.  Candida endophthalmitis associated with intravenous hyperalimentation.

Authors:  J B Freeman; P L Davis; L D MacLean
Journal:  Arch Surg       Date:  1974-02

Review 4.  Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis.

Authors:  J E Edwards; R Y Foos; J Z Montgomerie; L B Guze
Journal:  Medicine (Baltimore)       Date:  1974-01       Impact factor: 1.889

5.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

Review 6.  Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture.

Authors:  B R Jones
Journal:  Am J Ophthalmol       Date:  1975-05       Impact factor: 5.258

7.  Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients.

Authors:  B Dupont; E Drouhet
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

8.  Candida endophthalmitis after intravenous drug abuse.

Authors:  G L Aguilar; M S Blumenkrantz; P R Egbert; J P McCulley
Journal:  Arch Ophthalmol       Date:  1979-01

9.  Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size.

Authors:  J N Galgiani; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

10.  Ocular penetration of 5-fluorocytosine.

Authors:  A Walsh; D A Haft; M H Miller; M R Loran; A H Friedman
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-07       Impact factor: 4.799

View more
  32 in total

1.  Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

Authors:  D Debruyne
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

Review 2.  Discovery and development of new antimicrobial agents.

Authors:  T D Gootz
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

3.  In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.

Authors:  G S Kobayashi; S J Travis; M G Rinaldi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

Review 4.  Current approach to postoperative endophthalmitis.

Authors:  G Sunaric-Mégevand; C J Pournaras
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

Review 5.  Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

6.  Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  D Debruyne; J P Ryckelynck; M Moulin; B Hurault de Ligny; B Levaltier; M C Bigot
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 7.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

8.  Influence of local radiotherapy on penetration of fluconazole into human saliva.

Authors:  J Oliary; M Tod; K Louchahi; O Petitjean; B Frachet; V Le Gros; N Brion
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

9.  Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.

Authors:  Daoud Al-Badriyeh; Chin Fen Neoh; Kay Stewart; David C M Kong
Journal:  Clin Ophthalmol       Date:  2010-05-06

Review 10.  Clinical pharmacokinetics of fluconazole.

Authors:  D Debruyne; J P Ryckelynck
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.